AEBP1 | AE binding protein 1 | Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
AFF3 | AF4/FMR2 family, member 3 | Cancer-related genes Predicted intracellular proteins
| | | | | Mixed |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGL | Amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGPAT9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
AGTR1 | Angiotensin II receptor, type 1 | Disease related genes FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Group enriched |
AGTRAP | Angiotensin II receptor-associated protein | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
AHRR | Aryl-hydrocarbon receptor repressor | Predicted intracellular proteins Transcription factors
| | | | | Tissue enriched |
AIF1L | Allograft inflammatory factor 1-like | Predicted intracellular proteins
| | | | | Expressed in all |
AIFM1 | Apoptosis-inducing factor, mitochondrion-associated, 1 | Disease related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
AKAP1 | A kinase (PRKA) anchor protein 1 | Mitochondrial proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
AKAP10 | A kinase (PRKA) anchor protein 10 | Disease related genes Mitochondrial proteins Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
AKAP6 | A kinase (PRKA) anchor protein 6 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AKAP8L | A kinase (PRKA) anchor protein 8-like | Predicted intracellular proteins
| | | | | Expressed in all |
AKAP9 | A kinase (PRKA) anchor protein 9 | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
AKR1E2 | Aldo-keto reductase family 1, member E2 | Enzymes Predicted intracellular proteins
| | | | | Tissue enriched |
ALCAM | Activated leukocyte cell adhesion molecule | Cancer-related genes CD markers Plasma proteins Predicted membrane proteins
| | | | | Mixed |
ALDH5A1 | Aldehyde dehydrogenase 5 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
ALG6 | ALG6, alpha-1,3-glucosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALPI | Alkaline phosphatase, intestinal | Enzymes Predicted secreted proteins
| | | | | Group enriched |
ALPK1 | Alpha-kinase 1 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
ALPL | Alkaline phosphatase, liver/bone/kidney | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ALPP | Alkaline phosphatase, placental | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
ALPPL2 | Alkaline phosphatase, placental-like 2 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AMDHD2 | Amidohydrolase domain containing 2 | Enzymes Predicted intracellular proteins
| | | | | Expressed in all |
ANK3 | Ankyrin 3, node of Ranvier (ankyrin G) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
ANKS1B | Ankyrin repeat and sterile alpha motif domain containing 1B | Predicted intracellular proteins
| | | | | Tissue enriched |
ANO2 | Anoctamin 2, calcium activated chloride channel | Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO6 | Anoctamin 6 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ANPEP | Alanyl (membrane) aminopeptidase | CD markers Enzymes Plasma proteins Predicted membrane proteins
| | | | | Group enriched |
ANXA6 | Annexin A6 | Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
AP2M1 | Adaptor-related protein complex 2, mu 1 subunit | Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
AP3S2 | Adaptor-related protein complex 3, sigma 2 subunit | Predicted intracellular proteins
| | | | | Expressed in all |
AP5S1 | Adaptor-related protein complex 5, sigma 1 subunit | Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
APAF1 | Apoptotic peptidase activating factor 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
APC | Adenomatous polyposis coli | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
APH1A | APH1A gamma secretase subunit | Predicted membrane proteins
| | | | | Expressed in all |
APLF | Aprataxin and PNKP like factor | Enzymes G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Mixed |
APLP1 | Amyloid beta (A4) precursor-like protein 1 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
APLP2 | Amyloid beta (A4) precursor-like protein 2 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APMAP | Adipocyte plasma membrane associated protein | Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Expressed in all |
APOA2 | Apolipoprotein A-II | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOC4-APOC2 | APOC4-APOC2 readthrough (NMD candidate) | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOL6 | Apolipoprotein L, 6 | Predicted membrane proteins
| | | | | Expressed in all |
APOLD1 | Apolipoprotein L domain containing 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
APOO | Apolipoprotein O | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
APP | Amyloid beta (A4) precursor protein | Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
AQP1 | Aquaporin 1 (Colton blood group) | Blood group antigen proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
AQP10 | Aquaporin 10 | Predicted membrane proteins Transporters
| | | | | Group enriched |